Is subthalamic nucleus (STN) deep brain stimulation (DBS) effective for treating pain related to Parkinson disease (PD)?

Updated: Aug 29, 2019
  • Author: Robert A Hauser, MD, MBA; Chief Editor: Selim R Benbadis, MD  more...
  • Print

Although not specifically approved by the Food and Drug Administration (FDA) for pain, STN DBS may be effective in improving specific types of pain related to Parkinson disease, [90, 91] such as musculoskeletal pain [90, 92] and dystonic pain. However, there is a risk of postoperative deterioration of somatic pain exacerbated by Parkinson disease and radicular/peripheral neuropathic pain due to lumbar spine diseases. Patients with central pain have had a poor response to STN DBS. [90]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!